Some Things that You Should Know Regarding Bipolar Depression
You must understand that bipolar disorder is a kind of condition which affects all types of individuals. Both children and adults would get affected by such kind of condition. This is a fact that you should know. Those women would suffer the most from such type of depression which is known as bipolar depression disorder.
This isn’t very strange or far-fetched in any case, since even when the women would suffer from such regular bipolar kind of depression or the depressive disorder, they would often spend more time depressed than they do being manic. Not only women are depressive but the men also are and they could also be affected by this condition.
Such bipolar kind of disorder is called manic depression since such is one mental condition in which you would interchange often between the phases of mania as well as depression. When you suffer from bipolar depression, you will not have to spend as much time being manic as you spend being depressed.
This type of depression is one form of disorder and you should understand that it is really easy to wrongly diagnose as bipolar disorder due to the similarity in their symptoms. Due to such, the doctor should keep you around for a long time when they are going to try to diagnose the condition which you have. It certainly won’t be flattering to either of you when you are treated for a wrong thing.
The bipolar affective disorder is another name for such bipolar disorder or the manic-depressive illness. But, you don’t like to mistake this for bipolar depression disorder. Such is closely related with all of the symptoms of such depressive phase of the bipolar disorder, but very few of the mania.
The monotherapy trials against the placebo continue to be the gold-standard design when it comes to determining the efficacy in bipolar depression. If the efficacy would get proven as monotherapy, those new compounds can be tested in the adjunctive-medication placebo-controlled trials. Those younger adults, without such established need for the long-term medication can be suitable for those clinical trials that require placebo-controls. Such switch to mania or the hypomania can perhaps be the result of the active treatment for such bipolar depression.
Some of the medications like the tricyclic antidepressants as well as venlafaxine can be more likely to prove switch than the others but the increased rate of the switch cannot be seen until around ten weeks of treatment. The 12-week trials against placebo are needed to determine the risk of switch and also to establish the continuing effects. Know that such careful assessments at six to eight weeks are needed to ensure that the patients who fail to respond don’t continue in the study for such unacceptable periods of time.